Teladoc Historical Income Statement
| TDOC Stock | USD 10.62 0.22 2.12% |
Historical analysis of Teladoc income statement accounts such as Total Revenue of 2.7 B, Gross Profit of 1.9 B, Other Operating Expenses of 3 B or Research Development of 365.9 M can show how well Teladoc performed in making a profits. Evaluating Teladoc income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Teladoc's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Teladoc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Teladoc is a good buy for the upcoming year.
Teladoc |
About Teladoc Income Statement Analysis
Teladoc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Teladoc shareholders. The income statement also shows Teladoc investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Teladoc Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Teladoc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Teladoc minus its cost of goods sold. It is profit before Teladoc operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Teladoc income statement and is an important metric when analyzing Teladoc profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most accounts from Teladoc's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Teladoc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.At present, Teladoc's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling And Marketing Expenses is expected to grow to about 947.8 M, whereas Selling General Administrative is forecasted to decline to about 236 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 80.4M | 9.3M | 22.3M | 25.1M | Depreciation And Amortization | 219.6M | 270.6M | 351.3M | 368.9M |
Teladoc income statement Correlations
Click cells to compare fundamentals
Teladoc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Teladoc income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 45.0M | 78.1M | 219.6M | 270.6M | 351.3M | 368.9M | |
| Interest Expense | 29.0M | 60.5M | 80.4M | 9.3M | 22.3M | 25.1M | |
| Selling General Administrative | 164.5M | 506.7M | 438.0M | 449.9M | 464.7M | 236.0M | |
| Selling And Marketing Expenses | 174.6M | 380.2M | 667.3M | 850.7M | 902.6M | 947.8M | |
| Total Revenue | 553.3M | 1.1B | 2.0B | 2.4B | 2.6B | 2.7B | |
| Gross Profit | 368.8M | 703.1M | 1.4B | 1.7B | 1.8B | 1.9B | |
| Other Operating Expenses | 627.1M | 1.5B | 2.3B | 2.6B | 2.9B | 3.0B | |
| Operating Income | (73.8M) | (418.2M) | (239.0M) | (13.2B) | (248.6M) | (261.0M) | |
| Ebit | (73.8M) | (516.1M) | (304.3M) | (13.7B) | (197.3M) | (207.2M) | |
| Research Development | 64.6M | 164.9M | 311.9M | 333.6M | 348.5M | 365.9M | |
| Ebitda | (28.9M) | (438.0M) | (84.7M) | (13.5B) | 154.0M | 161.7M | |
| Cost Of Revenue | 184.5M | 390.8M | 650.3M | 744.0M | 760.0M | 798.0M | |
| Total Operating Expenses | 442.7M | 1.1B | 1.6B | 1.9B | 2.1B | 2.2B | |
| Income Before Tax | (109.5M) | (576.0M) | (384.7M) | (13.7B) | (219.6M) | (230.6M) | |
| Total Other Income Expense Net | (35.6M) | (69.6M) | (119.0M) | (26.9B) | 28.9M | 30.4M | |
| Net Income | (98.9M) | (485.1M) | (428.8M) | (13.7B) | (220.4M) | (231.4M) | |
| Income Tax Expense | (10.6M) | (90.9M) | 44.1M | (3.8M) | 760K | 798K | |
| Net Income From Continuing Ops | (98.9M) | (485.1M) | (428.8M) | (13.7B) | (220.4M) | (231.4M) | |
| Non Recurring | 6.6M | 88.2M | 26.6M | 13.4B | 15.4B | 16.2B | |
| Net Income Applicable To Common Shares | (98.9M) | (485.1M) | (428.8M) | (13.7B) | (12.3B) | (11.7B) | |
| Tax Provision | (10.6M) | (90.9M) | 44.1M | (3.8M) | 760K | 798K | |
| Interest Income | 26.1M | 29.0M | 776K | 12.7M | 46.8M | 49.1M | |
| Net Interest Income | (29.0M) | (60.5M) | (80.4M) | (9.3M) | 24.5M | 25.7M | |
| Reconciled Depreciation | 45.0M | 78.1M | 219.6M | 270.6M | 351.3M | 368.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.78) | Revenue Per Share 15.333 | Quarterly Revenue Growth (0.03) | Return On Assets (0.03) | Return On Equity (0.52) |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.